Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis

NCT01383603 is registered in ClinicalTrials.gov with Circassia Limited as lead sponsor.

NCT NCT01383603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01383603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis
Lead sponsor
Circassia Limited
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2011
Completion date
May 31, 2014
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cat allergy